1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Dec 2025
Admin
News Article

Fresenius Kabi Launches First Room-Temperature Stable Rocuronium Injection in the US

Fresenius Kabi has introduced a first-of-its-kind formulation of rocuronium bromide injection that does not require refrigeration. The new room-temperature stable (RTS) version marks a meaningful shift in how this critical anaesthesia drug is stored and distributed.

Why This Launch Matters?

Rocuronium bromide is widely used in hospitals during general anaesthesia. It facilitates tracheal intubation and provides skeletal muscle relaxation during surgery or mechanical ventilation.

Until now, storage requirements added operational complexity. With the RTS formulation, that changes.

Key Advantages of Rocuronium Bromide Injection RTS

The room-temperature stability delivers practical benefits across hospital systems:

No refrigeration needed, eliminating dependence on cold-chain logistics
Lower transportation and storage costs due to simplified handling
Easier inventory management for hospital pharmacies
Freed-up refrigerated space for other temperature-sensitive medicines

This is a logistics upgrade, not just a formulation change.

Made in the US, Built for Reliability

The new RTS formulation is:

Formulated, filled, and packaged in Grand Island, New York
Manufactured within Fresenius Kabi’s expanding US production network

Since 2017, the company has invested nearly $1 billion in US pharmaceutical manufacturing and distribution facilities.

More than 70% of Fresenius Kabi’s US shipments are drugs listed on the FDA’s Essential Medicines List.

Available Presentations

Rocuronium bromide injection RTS is available in two standard hospital-ready formats:

50 mg per 5 mL
100 mg per 10 mL

These formats align with routine clinical use in operating rooms and ICUs.

What Fresenius Kabi Says?

According to Joel Rosenstack, President, US Pharmaceuticals: The launch reflects Fresenius Kabi’s focus on innovation that improves efficiency while ensuring reliable access to essential medicines.

The emphasis is clear: operational efficiency, supply reliability, and patient care.

The Bigger Picture

This launch reinforces Fresenius Kabi’s positioning as a provider of essential, hospital-critical medicines. By removing cold-storage constraints, the company addresses a real-world pain point for healthcare systems.

Sometimes, innovation is not about new molecules. It is about making essential medicines easier to use, store, and deliver.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!